|
US2852520A
(en)
|
1957-01-08 |
1958-09-16 |
Searle & Co |
Trialkoxybenzoyloxyalkyl derivatives related to norharman
|
|
DE2856856A1
(de)
*
|
1978-01-09 |
1979-07-12 |
Sandoz Ag |
Fettsaeure-amid-und-hydracid derivate, ihre herstellung und ihre verwendung als pharmazeutika
|
|
US4448785A
(en)
*
|
1978-01-09 |
1984-05-15 |
Sandoz, Inc. |
N-Unsaturated fatty acid amides of tryptophan ester homologues and anti-cholesteric use thereof
|
|
US4185118A
(en)
|
1978-01-09 |
1980-01-22 |
Sandoz, Inc. |
Benzocycloalkylamides
|
|
US4194002A
(en)
|
1978-03-29 |
1980-03-18 |
Sandoz, Inc. |
Cholesterol ester-reducing amides of hexahydroindolinols
|
|
US4229463A
(en)
|
1978-02-27 |
1980-10-21 |
Sandoz, Inc. |
Unsaturated fatty acid hydrazides
|
|
US4201785A
(en)
|
1978-02-27 |
1980-05-06 |
Sandoz Inc. |
Cyclopropanyl-bearing hydrazides
|
|
US4248893A
(en)
|
1978-12-30 |
1981-02-03 |
Sandoz, Inc. |
Arterial wall cholesterol ester reducing cyclopropanyl-bearing amides
|
|
DE3105850A1
(de)
|
1981-02-18 |
1982-08-19 |
Horst, Hans Jörg, Priv.Doz.Dr., 2057 Reinbek |
Mittel zum behandeln von tumoren
|
|
CA1280414C
(en)
|
1985-03-15 |
1991-02-19 |
Saichi Matsumoto |
Isoprenoidamine derivatives and antiulcer agents
|
|
US4709094A
(en)
|
1986-07-10 |
1987-11-24 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Sigma brain receptor ligands and their use
|
|
US4906779A
(en)
|
1986-07-10 |
1990-03-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
|
|
US5093525A
(en)
|
1986-07-10 |
1992-03-03 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
|
|
US5190976A
(en)
|
1986-07-10 |
1993-03-02 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And University Of Oregon |
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
|
|
JPH0752542Y2
(ja)
|
1988-02-26 |
1995-11-29 |
東芝設備機器株式会社 |
冷却器
|
|
US4933324A
(en)
|
1988-02-26 |
1990-06-12 |
Shashoua Victor E |
Fatty acid-neuroactive drug conjugate as a prodrug
|
|
US5284876A
(en)
|
1988-02-26 |
1994-02-08 |
Neuromedica, Inc. |
Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents
|
|
US4939174A
(en)
|
1988-02-26 |
1990-07-03 |
Shashoua Victor E |
Appetite suppression with dopamine-fatty acid conjugates
|
|
US5994392A
(en)
|
1988-02-26 |
1999-11-30 |
Neuromedica, Inc. |
Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
|
|
US6107499A
(en)
|
1988-02-26 |
2000-08-22 |
Neuromedica, Inc. |
Dopamine analog amide
|
|
US4935422A
(en)
|
1988-12-15 |
1990-06-19 |
E. I. Du Pont De Nemours And Company |
Acyloxypropanolamines
|
|
US5175183A
(en)
|
1989-02-01 |
1992-12-29 |
Abbott Laboratories |
Lipoxygenase inhibiting compounds
|
|
IE68593B1
(en)
|
1989-12-06 |
1996-06-26 |
Sanofi Sa |
Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
|
|
JPH0625276Y2
(ja)
|
1989-12-29 |
1994-07-06 |
株式会社ワコール |
硬質線状体の押込み手作業用プロテクタ
|
|
IT1243846B
(it)
|
1990-10-17 |
1994-06-28 |
Pulitzer Italiana |
Derivato della melatonina ad attivita' terapeutica in dermatologia.
|
|
EP0590009B1
(en)
|
1991-06-19 |
1998-03-18 |
PHARMACIA & UPJOHN COMPANY |
Dialkyl (dialkoxyphosphinyl)methyl phosphates as anti-inflammatory agents
|
|
GB9218541D0
(en)
|
1991-09-30 |
1992-10-14 |
Ici Plc |
Fungicides
|
|
FR2706456B1
(fr)
|
1993-06-18 |
1996-06-28 |
Rhone Poulenc Agrochimie |
Dérivés optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
|
|
US5322858A
(en)
|
1992-02-14 |
1994-06-21 |
Jacobus Pharmaceutical Co. Inc. |
N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines
|
|
JPH0625276A
(ja)
|
1992-05-13 |
1994-02-01 |
Tanabe Seiyaku Co Ltd |
アシルアミノ糖誘導体及びその製法
|
|
US5585358A
(en)
|
1993-07-06 |
1996-12-17 |
Yissum Research Development Corporation Of The Hebrew University Of Jerusalem |
Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
|
|
EP0634402A1
(en)
|
1993-07-14 |
1995-01-18 |
Takeda Chemical Industries, Ltd. |
Isochinolinone derivatives, their production and use
|
|
JP3268073B2
(ja)
|
1993-08-17 |
2002-03-25 |
三菱製紙株式会社 |
可逆性感熱記録材料
|
|
US6869957B1
(en)
|
1993-11-17 |
2005-03-22 |
Eli Lilly And Company |
Non-peptide tachykinin receptor antagonists
|
|
US6403577B1
(en)
|
1993-11-17 |
2002-06-11 |
Eli Lilly And Company |
Hexamethyleneiminyl tachykinin receptor antagonists
|
|
ATE346595T1
(de)
*
|
1994-02-08 |
2006-12-15 |
Nps Pharma Inc |
An einer neuen stelle von rezeptorabhängigen kalziumkanälen wirkende verbindungen zur behandlung von neurologischen erkrankungen
|
|
DE69519963T2
(de)
*
|
1994-07-23 |
2001-06-21 |
Societe Des Produits Nestle S.A., Vevey |
Antioxidantzusammensetzung und Verfahren zu ihrer Herstellung
|
|
FR2724384B1
(fr)
|
1994-09-14 |
1999-04-16 |
Cemaf |
Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament
|
|
JP3795093B2
(ja)
|
1994-11-25 |
2006-07-12 |
キッセイ薬品工業株式会社 |
１−ヒドロキシインドール誘導体
|
|
JPH08157816A
(ja)
|
1994-12-02 |
1996-06-18 |
Oriza Yuka Kk |
天然抗酸化剤およびその製造方法
|
|
GB9426102D0
(en)
|
1994-12-23 |
1995-02-22 |
Merck Sharp & Dohme |
Pharmacuetical compositions
|
|
HUP9702388A3
(en)
|
1995-01-27 |
1999-01-28 |
Novo Nordisk As |
Compounds with growth hormone releasing properties and pharmaceuticals contg. them
|
|
FR2734814B1
(fr)
|
1995-05-31 |
1997-07-04 |
Adir |
Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
GB9513972D0
(en)
|
1995-07-08 |
1995-09-06 |
Merck Sharp & Dohme |
Pharmaceutical compositions
|
|
CA2203424A1
(en)
|
1995-08-21 |
1997-02-27 |
Eli Lilly And Company |
2-acylaminopropanamines as growth hormone secretagogues
|
|
US5821261A
(en)
|
1995-12-08 |
1998-10-13 |
Merck & Co., Inc. |
Substituted saturated aza heterocycles as inhibitors of nitric oxide synthase
|
|
US5849764A
(en)
*
|
1995-12-14 |
1998-12-15 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
|
JPH09301954A
(ja)
|
1996-05-14 |
1997-11-25 |
Kumiai Chem Ind Co Ltd |
Ｎ−（縮合ヘテロアリールアルキル）アルカン酸アミド誘導体及び農園芸用殺菌剤
|
|
US5795877A
(en)
|
1996-12-31 |
1998-08-18 |
Guilford Pharmaceuticals Inc. |
Inhibitors of NAALADase enzyme activity
|
|
US5902817A
(en)
|
1997-04-09 |
1999-05-11 |
Guilford Pharmaceuticals Inc. |
Certain sulfoxide and sulfone derivatives
|
|
US5977090A
(en)
|
1996-09-27 |
1999-11-02 |
Guilford Pharmaceuticals Inc. |
Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors
|
|
US5824662A
(en)
|
1996-09-27 |
1998-10-20 |
Guilford Pharmaceuticals Inc. |
Treatment of global and focal ischemia using naaladase inhibitors
|
|
US6025344A
(en)
|
1996-06-17 |
2000-02-15 |
Guilford Pharmaceuticals Inc. |
Certain dioic acid derivatives useful as NAALADase inhibitors
|
|
US6054444A
(en)
|
1997-04-24 |
2000-04-25 |
Guilford Pharmaceuticals Inc. |
Phosphonic acid derivatives
|
|
US6017903A
(en)
|
1996-09-27 |
2000-01-25 |
Guilford Pharmaceuticals Inc. |
Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
|
|
US5863536A
(en)
|
1996-12-31 |
1999-01-26 |
Guilford Pharmaceuticals Inc. |
Phosphoramidate derivatives
|
|
US6071965A
(en)
|
1996-06-17 |
2000-06-06 |
Guilford Pharmaceuticals Inc. |
Phosphinic alkanoic acid derivatives
|
|
US6046180A
(en)
|
1996-06-17 |
2000-04-04 |
Guilford Pharmaceuticals Inc. |
NAALADase inhibitors
|
|
US5700821A
(en)
|
1996-07-30 |
1997-12-23 |
University Of Pittsburgh |
Phosphatase inhibitors and methods of use thereof
|
|
AU6824396A
(en)
|
1996-08-09 |
1998-03-06 |
Sederma Sa |
Melatonin derivatives and their use in cosmetic or dermopharmaceutical compositions
|
|
JPH1077229A
(ja)
|
1996-09-03 |
1998-03-24 |
Sagami Chem Res Center |
自発運動抑制剤
|
|
JPH1077267A
(ja)
|
1996-09-03 |
1998-03-24 |
Sagami Chem Res Center |
５−メトキシトリプタミン誘導体
|
|
US5962521A
(en)
|
1997-04-04 |
1999-10-05 |
Guilford Pharmaceuticals Inc. |
Hydroxamic acid derivatives
|
|
GB9620777D0
(en)
|
1996-10-07 |
1996-11-20 |
Merck Sharp & Dohme |
Therapeutic use
|
|
AT2009U1
(de)
|
1997-01-24 |
1998-03-25 |
Trodat Werke Walter Just Gmbh |
Einrichtung zur ablage von handstempeln und anderen büroutensilien
|
|
RU2141483C1
(ru)
|
1997-07-04 |
1999-11-20 |
Небольсин Владимир Евгеньевич |
Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
|
|
CA2295697A1
(en)
|
1997-07-10 |
1999-01-21 |
Jason Scott Sawyer |
Inhibitors of neutrophil mediated oxidant production
|
|
CN1067527C
(zh)
|
1997-07-13 |
2001-06-27 |
赵宁斌 |
柿叶茶的制备方法
|
|
AP9801302A0
(en)
|
1997-07-23 |
2000-01-23 |
Pfizer |
Indole compounds as anti-inflammatory/analgesic agents..
|
|
US7041702B1
(en)
|
1997-10-21 |
2006-05-09 |
Scion Pharmaceuticals, Inc. |
Pharmaceutically active compounds and methods of use
|
|
HU227568B1
(en)
|
1997-12-24 |
2011-08-29 |
Sanofi Aventis Deutschland |
Indole derivatives, as inhibitors os factor xa
|
|
GB9804343D0
(en)
|
1998-02-27 |
1998-04-22 |
Univ Cardiff |
Chemical compounds
|
|
WO1999054442A1
(en)
|
1998-04-17 |
1999-10-28 |
Emory University |
Protein phosphatase methylesterase dna
|
|
FR2778671B1
(fr)
|
1998-05-14 |
2002-07-05 |
Rhone Poulenc Agrochimie |
Nouveau procede de preparation d'intermediaires de synthese
|
|
GB9812083D0
(en)
|
1998-06-05 |
1998-08-05 |
Ici Plc |
Removal of water
|
|
WO2000012045A2
(en)
|
1998-08-26 |
2000-03-09 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Method for treating neurodegenerative disorders
|
|
DE19842416A1
(de)
*
|
1998-09-16 |
2000-04-13 |
Max Planck Gesellschaft |
Sekundäre Amine zur Prävention und Therapie von Erkrankungen, die durch Oxidationsprozesse verursacht oder verstärkt werden
|
|
IL145771A0
(en)
|
1999-04-09 |
2002-07-25 |
Basf Ag |
Low-molecular inhibitors of complement proteases
|
|
US6503949B1
(en)
|
1999-05-17 |
2003-01-07 |
Noro Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
WO2001021606A1
(en)
|
1999-09-21 |
2001-03-29 |
Qinetiq Limited |
Liquid crystal compounds
|
|
AU7832000A
(en)
|
1999-09-23 |
2001-04-24 |
Washington University |
Compounds directed against pilus biogenesis and activity in pathogenic bacteria;methods and compositions for synthesis thereof
|
|
US20030036070A1
(en)
|
1999-10-21 |
2003-02-20 |
Shukti Chakravarti |
Gene expression profiling of inflammatory bowel disease
|
|
FR2802206B1
(fr)
|
1999-12-14 |
2005-04-22 |
Sod Conseils Rech Applic |
Derives de 4-aminopiperidine et leur utilisation en tant que medicament
|
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
|
US6372752B1
(en)
|
2000-02-07 |
2002-04-16 |
Genzyme Corporation |
Inha inhibitors and methods of use thereof
|
|
US6653304B2
(en)
|
2000-02-11 |
2003-11-25 |
Bristol-Myers Squibb Co. |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
|
|
JP2001247539A
(ja)
|
2000-03-03 |
2001-09-11 |
Hunan Research Inst Of Chemical Industry |
殺生物性のアルキル置換された（ヘテロ）アリール‐ケトキシム‐ｏ‐エーテルおよびその製造方法
|
|
AU779041B2
(en)
|
2000-05-02 |
2005-01-06 |
Meiji Seika Kaisha Ltd. |
Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
|
|
US20020034524A1
(en)
|
2000-06-19 |
2002-03-21 |
Poret Jacques Louis |
Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces
|
|
US6562807B2
(en)
|
2000-06-23 |
2003-05-13 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
CA2321348A1
(en)
|
2000-09-27 |
2002-03-27 |
Blaise Magloire N'zemba |
Aromatic derivatives with hiv integrase inhibitory properties
|
|
US20040053963A1
(en)
|
2000-12-11 |
2004-03-18 |
Dashyant Dhanak |
Urotensin-II receptor antagonists
|
|
JP2002193923A
(ja)
|
2000-12-26 |
2002-07-10 |
Taisho Pharmaceut Co Ltd |
アミノ安息香酸誘導体
|
|
WO2003080556A1
(en)
|
2001-01-19 |
2003-10-02 |
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. |
Amine derivative with potassium channel regulatory function, its preparation and use
|
|
JP2004524295A
(ja)
|
2001-01-26 |
2004-08-12 |
スミスクライン・ビーチャム・コーポレイション |
ウロテンシン−ｉｉ受容体アンタゴニスト
|
|
US7173027B2
(en)
|
2001-01-29 |
2007-02-06 |
University Of Connecticut |
Receptor selective cannabimimetic aminoalkylindoles
|
|
US7820144B2
(en)
|
2001-01-29 |
2010-10-26 |
University Of Connecticut |
Receptor selective cannabimimetic aminoalkylindoles
|
|
AUPR392301A0
(en)
|
2001-03-23 |
2001-04-26 |
University Of Newcastle Research Associates Limited, The |
Protein phosphatase inhibitors
|
|
US20040138224A1
(en)
|
2002-03-28 |
2004-07-15 |
Dashyant Dhanak |
Pyrrolidine sulfonamides
|
|
WO2002079155A1
(en)
|
2001-03-29 |
2002-10-10 |
Smithkline Beecham Corporation |
Pyrrolidine sulfonamides
|
|
EP1392639B1
(en)
|
2001-05-03 |
2008-09-17 |
Galileo Laboratories, Inc. |
Pyruvate derivatives
|
|
US6608196B2
(en)
|
2001-05-03 |
2003-08-19 |
Galileo Pharmaceuticals, Inc. |
Process for solid supported synthesis of pyruvate-derived compounds
|
|
SE0101978D0
(sv)
|
2001-06-01 |
2001-06-01 |
Astrazeneca Ab |
New compounds
|
|
WO2003008632A1
(en)
|
2001-07-16 |
2003-01-30 |
Hoegestaett Edward |
Fatty acid conjugation as a method for screening of potentially bioactive substances
|
|
US7262268B2
(en)
*
|
2001-08-06 |
2007-08-28 |
Cubist Pharmaceuticals, Inc. |
Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
|
|
AU2002324666B2
(en)
|
2001-08-10 |
2007-10-11 |
The Rockefeller University |
Compostions and methods for modulation of DARPP-32 phosphorylation
|
|
AU2002336532C1
(en)
|
2001-09-14 |
2008-10-16 |
Amgen, Inc |
Linked biaryl compounds
|
|
US20030215456A1
(en)
|
2001-10-02 |
2003-11-20 |
Sui-Long Yao |
Method of treating cancer
|
|
AU2002342859B2
(en)
|
2001-10-30 |
2007-07-26 |
Merck Serono Sa |
Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPS)
|
|
JP4156825B2
(ja)
|
2001-11-01 |
2008-09-24 |
株式会社ロッテ |
抗鬱・抗ストレス剤及びそれを含有する組成物
|
|
AU2002363177B2
(en)
|
2001-11-01 |
2008-09-18 |
Janssen Pharmaceutica N.V. |
Aminobenzamide derivatives as glycogen synthase kinase 3Beta inhibitors
|
|
CN1205175C
(zh)
|
2001-11-02 |
2005-06-08 |
中国人民解放军军事医学科学院毒物药物研究所 |
胺衍生物在制备具有抗肺动脉高压作用的药物中用途
|
|
US20030171411A1
(en)
|
2001-12-21 |
2003-09-11 |
Kodra Janos Tibor |
Amide derivatives as therapeutic agents
|
|
US7794965B2
(en)
|
2002-03-13 |
2010-09-14 |
Signum Biosciences, Inc. |
Method of identifying modulators of PP2A methylase
|
|
US20040138238A1
(en)
|
2002-08-08 |
2004-07-15 |
Dhanoa Dale S. |
Substituted aminopyrimidine compounds as neurokinin antagonists
|
|
WO2004031177A1
(ja)
|
2002-09-30 |
2004-04-15 |
Banyu Pharmaceutical Co., Ltd. |
２−アミノベンズイミダゾール誘導体
|
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
|
DE10300099A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Indol-Phenylsulfonamid-Derivate
|
|
WO2004063147A1
(en)
|
2003-01-10 |
2004-07-29 |
Novo Nordisk A/S |
Salts and solvates of glucagon antagonists
|
|
JP5208411B2
(ja)
|
2003-02-06 |
2013-06-12 |
ドムペ・ファ．ル．マ・ソチエタ・ペル・アツィオーニ |
２−アリール−酢酸、その誘導体、及びそれらを含有する医薬組成物
|
|
JP4421832B2
(ja)
|
2003-03-27 |
2010-02-24 |
株式会社常磐植物化学研究所 |
記憶促進剤
|
|
AU2004236247B2
(en)
|
2003-04-30 |
2008-11-06 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1 B
|
|
WO2005001041A2
(en)
|
2003-05-28 |
2005-01-06 |
Paul Anziano |
Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
|
|
NZ545747A
(en)
|
2003-08-06 |
2010-06-25 |
Senomyx Inc |
T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
|
|
WO2005014532A1
(en)
|
2003-08-08 |
2005-02-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
WO2005019168A2
(en)
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
|
|
US7282593B2
(en)
|
2003-09-11 |
2007-10-16 |
Board Of Trustees Of Michigan State University |
Withanamide and withanolide compositions and method of use thereof
|
|
FR2860793A1
(fr)
|
2003-10-14 |
2005-04-15 |
Entomed |
Composes derives de norcantharidine, leurs procedes de preparation, les compositions les contenant et leurs utilisations
|
|
DE602004011985T2
(de)
|
2003-11-25 |
2009-03-05 |
Eli Lilly And Co., Indianapolis |
Modulatoren des peroxisomproliferatoraktivierten rezeptors
|
|
CA2548281C
(en)
|
2003-12-09 |
2013-11-12 |
Medcrystalforms, Llc |
Method of preparation of mixed phase co-crystals with active agents
|
|
WO2005071101A1
(en)
|
2004-01-23 |
2005-08-04 |
University Hospital Of Basel |
Treatment of hepatitis c infection by increasing stat1 methylation
|
|
EP1711495A2
(en)
|
2004-01-23 |
2006-10-18 |
Amgen Inc. |
Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer
|
|
US8053462B2
(en)
|
2004-03-08 |
2011-11-08 |
Masanori Somei |
Indole derivative and application thereof
|
|
EP1744751A4
(en)
|
2004-03-18 |
2010-03-10 |
Brigham & Womens Hospital |
METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES
|
|
AU2006230674A1
(en)
|
2004-03-18 |
2006-11-16 |
The Brigham And Women's Hospital, Inc. |
Methods for the Treatment of Synucleinopathies
|
|
CA2561801A1
(en)
|
2004-04-02 |
2005-10-20 |
Elixir Pharmaceuticals, Inc. |
Sulfonamides and uses thereof
|
|
CN101031289A
(zh)
|
2004-04-26 |
2007-09-05 |
范德比尔特大学 |
作为具有降低胃肠毒性的治疗剂的吲哚乙酸和茚乙酸衍生物
|
|
US20050250819A1
(en)
|
2004-05-07 |
2005-11-10 |
Xiaobing Li |
Inhibitors of bacterial type III protein secretion systems
|
|
FR2872704B1
(fr)
|
2004-07-12 |
2007-11-02 |
Laurent Schwartz |
Pluritherapie contre le cancer
|
|
US20060045953A1
(en)
|
2004-08-06 |
2006-03-02 |
Catherine Tachdjian |
Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
|
|
EP1790640A4
(en)
|
2004-09-09 |
2009-07-29 |
Chugai Pharmaceutical Co Ltd |
NEW IMIDAZOLIDINE DERIVATIVE AND APPLICATION THEREOF
|
|
JP3964417B2
(ja)
|
2004-09-27 |
2007-08-22 |
国立大学法人金沢大学 |
インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
|
|
CA2585934C
(en)
|
2004-10-29 |
2013-09-10 |
Abbott Laboratories |
Novel pyrazolopyridine urea kinase inhibitors
|
|
ES2321858T3
(es)
|
2004-11-11 |
2009-06-12 |
Ferrer Internacional, S.A. |
Compuestos de imidazo(1,2-a)piridina, composiciones, usos y metodos relacionados.
|
|
US20060160109A1
(en)
|
2004-11-22 |
2006-07-20 |
Odyssey Thera, Inc. |
Harnessing network biology to improve drug discovery
|
|
US20070212677A1
(en)
|
2004-11-22 |
2007-09-13 |
Odyssey Thera, Inc. |
Identifying off-target effects and hidden phenotypes of drugs in human cells
|
|
CA2587664A1
(en)
|
2004-12-21 |
2006-06-29 |
Devgen N.V. |
Compounds with kv4 ion channel activity
|
|
FR2879601B1
(fr)
|
2004-12-22 |
2007-01-19 |
Galderma Res & Dev |
Nouveaux composes derives d'acide phenyl-boronique et leur procede de preparation
|
|
EP1676842A1
(en)
|
2004-12-30 |
2006-07-05 |
Laboratorios Del Dr. Esteve, S.A. |
Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
|
|
US20070161644A1
(en)
|
2005-01-25 |
2007-07-12 |
Stockwell Brent R |
Erastin analogs and uses thereof
|
|
AU2006209245A1
(en)
|
2005-01-28 |
2006-08-03 |
Irm Llc |
Phenyl-substituted pyrrolidones
|
|
US8221804B2
(en)
*
|
2005-02-03 |
2012-07-17 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
EP1853590A1
(en)
|
2005-03-03 |
2007-11-14 |
Sirtris Pharmaceuticals, Inc. |
Fused heterocyclic compounds and their use as sirtuin modulators
|
|
WO2006101456A1
(en)
|
2005-03-21 |
2006-09-28 |
S*Bio Pte Ltd |
Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors
|
|
JP2008534593A
(ja)
|
2005-03-30 |
2008-08-28 |
メルク エンド カムパニー インコーポレーテッド |
グルカゴン受容体アンタゴニスト化合物、そのような化合物を含む組成物、及びその使用方法
|
|
CN1304396C
(zh)
|
2005-04-08 |
2007-03-14 |
中山大学 |
斑蝥素衍生物及其制备方法
|
|
TW200738677A
(en)
|
2005-06-27 |
2007-10-16 |
Elbion Ag |
Nitro-substituted hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
|
|
WO2007008514A2
(en)
|
2005-07-07 |
2007-01-18 |
Georgetown University |
Inhibitors of glycogen synthase kinase 3
|
|
WO2007015866A2
(en)
|
2005-07-20 |
2007-02-08 |
Kalypsys, Inc. |
Inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
JP2009504712A
(ja)
|
2005-08-17 |
2009-02-05 |
ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
カリウムチャンネル阻害化合物の使用方法
|
|
EP1931632A4
(en)
|
2005-08-18 |
2011-05-11 |
Microbia Inc |
USEFUL INDOOR CONNECTIONS
|
|
AU2006302371A1
(en)
|
2005-10-06 |
2007-04-19 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding cassette transporters
|
|
US20080021198A1
(en)
|
2005-10-12 |
2008-01-24 |
Yigong Shi |
Modulators of protein phosphatase 2A and PP2A methyl esterase
|
|
US7902251B2
(en)
|
2005-10-19 |
2011-03-08 |
Allergan, Inc. |
Method for treating pain
|
|
US20070105940A1
(en)
|
2005-10-19 |
2007-05-10 |
Allergan, Inc. |
Method for treating pain
|
|
US20070259945A1
(en)
|
2005-10-19 |
2007-11-08 |
Allergan, Inc. |
Method for treating pain
|
|
JP4993900B2
(ja)
|
2005-11-28 |
2012-08-08 |
国立大学法人 東京医科歯科大学 |
記憶障害抑制剤
|
|
CN1974545B
(zh)
*
|
2005-11-29 |
2010-05-26 |
上海第二医科大学 |
长链脂肪酰胺类化合物及其应用
|
|
DE102005061428A1
(de)
|
2005-12-22 |
2007-08-16 |
Grünenthal GmbH |
Substituierte Cyclohexylmethyl-Derivate
|
|
AR059826A1
(es)
|
2006-03-13 |
2008-04-30 |
Univ California |
Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
|
|
GB0611417D0
(en)
|
2006-06-09 |
2006-07-19 |
Leuven K U Res & Dev |
Treatment of cndaria intoxication
|
|
CA2657093A1
(en)
|
2006-07-07 |
2008-01-10 |
Steven P. Govek |
Bicyclic heteroaryl inhibitors of pde4
|
|
WO2008007123A2
(en)
|
2006-07-14 |
2008-01-17 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
AU2007281747B2
(en)
|
2006-08-07 |
2013-11-07 |
Ironwood Pharmaceuticals, Inc. |
Indole compounds
|
|
RU2446157C2
(ru)
|
2006-09-13 |
2012-03-27 |
Санофи-Авентис |
Изосериновые производные для применения в качестве ингибиторов фактора свертывания крови ixa
|
|
EP2068869A4
(en)
|
2006-10-06 |
2011-05-25 |
Abbott Lab |
NEW IMIDAZOTHIAZOLE AND IMIDAZOXAZOLE
|
|
US7960569B2
(en)
|
2006-10-17 |
2011-06-14 |
Bristol-Myers Squibb Company |
Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
EP2076513A1
(en)
|
2006-10-20 |
2009-07-08 |
Irm Llc |
Compositions and methods for modulating c-kit and pdgfr receptors
|
|
GB0623258D0
(en)
|
2006-11-22 |
2007-01-03 |
Remynd Nv |
Thiadiazole derivatives for the treatment of neuro-degenerative diseases
|
|
JP4771975B2
(ja)
|
2007-02-27 |
2011-09-14 |
三菱製紙株式会社 |
可逆性感熱記録材料
|
|
US20100184803A1
(en)
|
2007-03-09 |
2010-07-22 |
Link Medicine Corporation |
Treatment of Lysosomal Storage Diseases
|
|
EA200970841A1
(ru)
|
2007-03-09 |
2010-04-30 |
ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Фармацевтическое применение замещенных амидов
|
|
DE102007012284A1
(de)
|
2007-03-16 |
2008-09-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2008141013A1
(en)
|
2007-05-08 |
2008-11-20 |
Allergan, Inc. |
S1p3 receptor inhibitors for treating pain
|
|
EP1992621A1
(en)
|
2007-05-16 |
2008-11-19 |
Sanofi-Aventis |
Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
|
|
EP1992624A1
(en)
|
2007-05-16 |
2008-11-19 |
Sanofi-Aventis |
Heteroarylamide pyrimidone compounds
|
|
US20110236953A1
(en)
|
2007-08-03 |
2011-09-29 |
Beth Israel Deaconness Medical Center |
EMBRYONIC CEREBROSPINAL FLUID (e-CSF), PROTEINS FROM e-CSF, AND RELATED METHODS AND COMPOSITIONS
|
|
EP2282735B1
(en)
|
2008-04-21 |
2019-01-16 |
Signum Biosciences, Inc. |
Pp2a modulators for treating alzheimer, parkinson, diabetes
|
|
JP4842996B2
(ja)
|
2008-06-09 |
2011-12-21 |
株式会社ロッテ |
抗鬱・抗ストレス組成物
|
|
CN115941304B
(zh)
|
2022-11-29 |
2025-10-03 |
深圳云里物里科技股份有限公司 |
数据的加密方法、装置、终端设备和计算机可读存储介质
|